Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL6363812 | 0.93 | ALDH1A1 (0.43) | ALDH1A1TSHRHPGDSMN1; SMN2L3MBTL1 | |
| Biphenyl SCHEMBL27502287 | 0.91 | MEN1 (0.43) | ALDH1A1TSHRSMN1; SMN2PTPN1GPR84 | |
| Biphenyl SCHEMBL9418891 | 0.91 | MEN1 (0.43) | ALDH1A1TSHRSMN1; SMN2PTPN1GPR84 | |
| Biphenyl SCHEMBL843117 | 0.87 | ALDH1A1 (0.53) | ALDH1A1TSHRHPGDSMN1; SMN2L3MBTL1 | |
| Biphenyl SCHEMBL5868585 | 0.84 | ALDH1A1 (0.56) | ALDH1A1TSHRHPGDSMN1; SMN2L3MBTL1 | |
| Biphenyl SCHEMBL15347228 | 0.84 | ALDH1A1 (0.56) | ALDH1A1TSHRHPGDSMN1; SMN2L3MBTL1 | |
| Benzene SCHEMBL27714186 | 0.84 | TSHR (0.40) | TSHRSMN1; SMN2PCSK9MAPTLTA4H | |
| SCHEMBL28411177 | 0.83 | CES2 (0.39) | TSHRSMN1; SMN2PCSK9LTA4H | |
| Toluene SCHEMBL3671880 | 0.83 | TSHR (0.52) | TSHRHPGDSMN1; SMN2PCSK9LTA4H | |
| Toluene SCHEMBL11618017 | 0.83 | TSHR (0.52) | TSHRHPGDSMN1; SMN2PCSK9LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107021941-A | Ionic liquid and preparation method thereof | 微宏动力系统（湖州）有限公司 | 2017-08-08 | — | — | CN | claimed |
| CN-104710475-B | A kind of preparation method of quaternary salt | MICROVAST POWER SYSTEM (HUZHOU) CO., LTD. (CN) | 2016-11-30 | — | — | CN | claimed |
| CN-105826596-A | Preparation method for ionic liquid and secondary battery | 微宏动力系统（湖州）有限公司 | 2016-08-03 | — | — | CN | claimed |
| CN-104710475-A | Preparation method of quaternary phosphonium salt | MICROVAST POWER SYSTEMS HUZHOU CO LTD | 2015-06-17 | — | — | CN | claimed |
| US-20050222452-A1 | Process for preparing dioxy-functionalized propane compounds | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2005-10-06 | — | — | US | claimed |
| EP-0119899-B1 | PROCESS FOR THE PREPARATION OF 4-PENTENOIC ACID DERIVATIVES | ROUSSEL-UCLAF (FR) | 1986-03-05 | — | — | EP | claimed |
| EP-0119899-A1 | Process for the preparation of 4-pentenoic acid derivatives | ROUSSEL-UCLAF (FR) | 1984-09-26 | — | — | EP | claimed |
| US-20240239778-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-07-18 | — | — | US | disclosed |
| US-11993593-B2 | Griseofulvin compound and pharmaceutical use thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-28 | — | — | US | disclosed |
| US-20220411416-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2022-12-29 | — | — | US | disclosed |
| US-11407746-B2 | Griseofulvin compound and pharmaceutical use thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2022-08-09 | — | — | US | disclosed |
| EP-3689857-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-20200216433-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2020-07-09 | — | — | US | disclosed |
| US-6348611-B1 | NEUTRAL OR CATIONIC TRANSITION METAL CATALYST FOR USE IN HYDROFORMYLATION OF EPOXIDE DERIVATIVES | SAMSUNG ELECTRONIC CO., KTD. (KR) | 2002-02-19 | — | — | US | disclosed |
| EP-1034842-A2 | Transition metal complex catalyst for the carbonylation of epoxide derivatives | Samsung Electronics Co., Ltd. (KR) | 2000-09-13 | — | — | EP | disclosed |
| CN-1238749-A | Highly branched primary alcohol compositions and biodegradable detergents made therefrom | SHELL INT RESEARCH (NL) | 1999-12-15 | — | — | CN | disclosed |
| CN-1228799-A | Moulding compound consisting of polycarbonate mixture and siloxane reticular rubber | BASF AG (DE) | 1999-09-15 | — | — | CN | disclosed |
| US-4670577-A | Novel process | ROUSSEL UCLAF (FR) | 1987-06-02 | — | — | US | disclosed |
| EP-0119899-B1 | PROCESS FOR THE PREPARATION OF 4-PENTENOIC ACID DERIVATIVES | ROUSSEL-UCLAF (FR) | 1986-03-05 | — | — | EP | disclosed |
| EP-0119899-A1 | Process for the preparation of 4-pentenoic acid derivatives | ROUSSEL-UCLAF (FR) | 1984-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11407746-B2 | Griseofulvin compound and pharmaceutical use thereof | ACBD3, GRN, NR3C1 | ALDH1A1 1162/4885TSHR 3217/4885HPGD 1061/4885 |
| US-20240239778-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | ACBD3, NR3C1, GRN | ALDH1A1 1113/4885TSHR 3242/4885HPGD 1011/4885 |
| US-20200216433-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | ACBD3, NR3C1, GRN | ALDH1A1 1113/4885TSHR 3242/4885HPGD 1011/4885 |
| US-20050222452-A1 | Process for preparing dioxy-functionalized propane compounds | PPOX, CDYL, SCO2 | ALDH1A1 2227/4885TSHR 1636/4885HPGD 340/4885 |
| US-11993593-B2 | Griseofulvin compound and pharmaceutical use thereof | ACBD3, GRN, C1S | ALDH1A1 1136/4885TSHR 3252/4885HPGD 1015/4885 |
| US-20220411416-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | ACBD3, NR3C1, GRN | ALDH1A1 1113/4885TSHR 3242/4885HPGD 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.